SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 39 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,252,647 | +4.1% | 5,198,000 | 0.0% | 0.20% | +6.5% |
| Q2 2023 | $8,887,187 | -23.2% | 5,198,000 | -12.6% | 0.19% | -19.1% |
| Q1 2023 | $11,571,045 | -83.9% | 5,948,000 | -84.5% | 0.23% | -86.6% |
| Q4 2022 | $71,834,226 | +12.0% | 38,394,000 | 0.0% | 1.71% | +16.4% |
| Q3 2022 | $64,158,000 | +423.5% | 38,394,000 | +667.9% | 1.47% | +326.1% |
| Q4 2020 | $12,256,000 | +18.1% | 5,000,000 | 0.0% | 0.34% | -12.9% |
| Q3 2020 | $10,382,000 | -39.8% | 5,000,000 | -33.3% | 0.40% | -49.2% |
| Q2 2020 | $17,246,000 | +49.6% | 7,500,000 | 0.0% | 0.78% | +39.5% |
| Q1 2020 | $11,527,000 | -50.7% | 7,500,000 | -37.5% | 0.56% | -55.4% |
| Q4 2019 | $23,393,000 | -26.5% | 12,000,000 | -50.0% | 1.25% | -35.7% |
| Q3 2019 | $31,832,000 | -64.3% | 24,000,000 | -40.0% | 1.95% | -56.6% |
| Q2 2019 | $89,055,000 | +11.4% | 40,000,000 | -9.3% | 4.49% | -5.2% |
| Q1 2019 | $79,962,000 | +8.2% | 44,113,000 | 0.0% | 4.74% | -2.9% |
| Q4 2018 | $73,926,000 | – | 44,113,000 | – | 4.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |